Sort   by:  
 Page size 
UnknownComparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures.
Not available
S-EPMC10827834 | biostudies-literature
UnknownCost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States.
Not available
S-EPMC10232643 | biostudies-literature
UnknownSkeletal responses to romosozumab after 12 months of denosumab.
Not available
S-EPMC8260819 | biostudies-literature
UnknownA single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab.
Not available
S-EPMC7560921 | biostudies-literature
UnknownValidation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia.
Not available
S-EPMC5377391 | biostudies-literature
UnknownMeasuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.
Not available
S-EPMC10363087 | biostudies-literature
UnknownOutcome Priorities for Older Persons With Sarcopenia.
Not available
S-EPMC7021510 | biostudies-literature
UnknownFalls prevention in community-dwelling older adults and implementation of world falls guidelines: a call for action across Europe by the European Geriatric Medicine Society Special Interest Group on Falls and Fractures.
Not available
S-EPMC12378773 | biostudies-literature
UnknownPhysical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline.
Not available
S-EPMC10587099 | biostudies-literature
Sort   by:  
 Page size